A retrospective, multicenter study of simeprevir and sofosbuvir with or without ribavirin in liver transplant patients with hepatitis C virus genotype 1 and 4 infection.

Trial Profile

A retrospective, multicenter study of simeprevir and sofosbuvir with or without ribavirin in liver transplant patients with hepatitis C virus genotype 1 and 4 infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 14 Dec 2016 New trial record
    • 01 Nov 2016 Results published in the Transplantation Proceedings.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top